sub:assertion {
d:DB00923 v:identifier "DB00923" ;
v:namespace "drugbank" ;
v:uri "http://bio2rdf.org/drugbank:DB00923" ;
v:x-identifiers.org <
http://identifiers.org/drugbank/DB00923> ;
dv:drugbank-id "APRD00853" , "DB00923" ;
dv:x-atc <
http://bio2rdf.org/atc:J01DC11> ;
dv:x-cas <
http://bio2rdf.org/cas:60925-61-3> ;
dv:x-chebi <
http://bio2rdf.org/chebi:3495> ;
dv:x-chemspider <
http://bio2rdf.org/chemspider:39656> ;
dv:x-kegg <
http://bio2rdf.org/kegg:C06884> , <
http://bio2rdf.org/kegg:D00259> ;
dv:x-pharmgkb <
http://bio2rdf.org/pharmgkb:PA164746057> ;
dv:x-pubchemcompound <
http://bio2rdf.org/pubchem.compound:43507> ;
dv:x-pubchemsubstance <
http://bio2rdf.org/pubchem.substance:46504532> ;
dv:x-wikipedia <
http://bio2rdf.org/wikipedia:Ceforanide> ;
dct:description "Ceforanide is a second-generation parenteral cephalosporin antibiotic. It has a longer elimination half-life than any currently available cephalosporin. Its activity is very similar to that of cefamandole, a second-generation cephalosporin, except that ceforanide is less active against most gram-positive organisms. Many coliforms, including Escherichia coli, Klebsiella, Enterobacter, and Proteus, are susceptible to ceforanide, as are most strains of Salmonella, Shigella, Hemophilus, Citrobacter and Arizona species."@en ;
dct:identifier "drugbank:DB00923" ;
dct:title "Ceforanide"@en ;
a dv:Drug ;
rdfs:label "Ceforanide [drugbank:DB00923]"@en ;
rdfs:seeAlso <
http://www.drugbank.ca/drugs/DB00923> .
}